Industry
Featured experience
Novo Nordisk acquisition of certain Catalent sites from Novo Holdings
We are advising Novo Nordisk on the acquisition
AbbVie $15 billion senior notes offering
The investment-grade offering comprised seven tranches
Auna $360 million U.S. IPO
We advised Auna on its U.S. IPO and NYSE listing
Trial victory in patent infringement case for Magnolia Medical Technologies
We served as lead trial counsel for Magnolia Medical in an action against its sole competitor
Adamas Pharmaceuticals $59 million stock offering
We advised the joint book-running managers on the SEC-registered equity offering
AVITA Medical $69.1 million follow-on offering
We advised the underwriters on the equity offering
I-Mab $177 million follow-on secondary offering of ADSs
We advised the underwriters on the equity offering
Evernorth acquisition of MDLIVE
We are advising MDLIVE on the transaction
JOINN Laboratories HK$6.5 billion IPO
We advised JOINN Laboratories on its IPO and HKEX listing.
Reckitt Benckiser Group acquisition of Biofreeze
We are advising RB on the acquisition
Ayala Pharmaceuticals $25 million private placement
We advised the placement agent on the private placement of stock and warrants
InnoCare Pharma HK$3.04 billion share placement
We advised InnoCare Pharma in the placement of new shares
New Horizon Health HK$2.04 billion IPO
We advised New Horizon Health on its IPO and HKEX listing
Akeso HK$1.19 billion share placement
We advised the placing agent in the placement of new shares